Target genes of non-canonical NF-κB pathway have been shown to include BLIMP-1 (via RelB, albeit in tumor cells) [104], suggesting this gene may be an early regulator of the exhaustion transcriptional network. The gene discussed is PRDM1; the disease is neoplasm.